EvoluteIQ is a technology company.
EvoluteIQ has raised $20.0M across 1 funding round.
EvoluteIQ has raised $20.0M in total across 1 funding round.
EvoluteIQ is a technology company specializing in AI-native agentic automation through its EIQ platform, which unifies process orchestration, generative AI, robotic process automation (RPA), machine learning, and no-code/low-code tools to enable end-to-end business process transformation.[1][2][3][5] The platform serves enterprises in sectors like healthcare, banking, finance, insurance, and manufacturing, solving fragmented processes by creating adaptive, self-correcting workflows that boost efficiency, cut costs by up to 70%, improve customer experience by up to 60%, and deliver go-live in under 7 weeks.[2][3][5][6] With a 170%+ net retention rate and trust from Fortune 500 clients like Omega Healthcare, EvoluteIQ drives measurable growth, including revenue increases up to 40% and workforce productivity gains up to 90%.[2][5]
Founded in 2019 and headquartered in Stockholm, Sweden, with presence in the UK, US, and India, EvoluteIQ emerged from the recognition that enterprise processes had become fragmented by siloed systems, bots, and bolt-on AI, hindering innovation.[1][2][4] Co-founder and CEO Sameet Gupte leads the charge, backed by Nordea and Confidus Venture Capital, and selected among 8 from 700 firms for PwC's 2022 Scale FinTech programme.[1][4] Early traction came from addressing this "stitching" problem with an AI-native platform, evolving from hyperautomation enablement to agentic automation that thinks, acts, and improves autonomously, powering partnerships like with The DDC Group and InfoVision.[1][2][5]
EvoluteIQ rides the agentic AI wave, where automation shifts from task-level bots to autonomous, resilient ecosystems amid rising enterprise complexity and AI adoption—Gartner predicts 70% of organizations will use AI-driven decisions by 2025.[2][6] Timing aligns with digital transformation demands post-fragmented legacy systems, amplified by GenAI for healthcare revenue cycle management, banking processes, and beyond, as seen in partnerships enhancing RCM for Omega Healthcare.[1][3][5] It influences the ecosystem by accelerating hyperautomation adoption, reducing integration pains, and enabling industries to evolve processes into competitive advantages, positioning no-code AI platforms as essential for sustainable scaling.[2][4][6]
EvoluteIQ is primed to dominate agentic automation as enterprises prioritize end-to-end AI over piecemeal tools, with expansions into more verticals like manufacturing via global footprints and Fortune 500 wins.[2][5] Trends like Forrester's 3.4x efficiency gains and McKinsey's 50% cost reductions will fuel growth, evolving its influence toward ecosystem-wide standards for resilient processes.[6] As the only AI-native platform humanizing complexity into adaptive intelligence, EvoluteIQ doesn't just automate businesses—it evolves them.[2]
EvoluteIQ has raised $20.0M in total across 1 funding round.
EvoluteIQ's investors include Business Growth Fund, Confidus Venture Capital, Round2 Capital Partners.
EvoluteIQ has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Venture Round in October 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2024 | $20.0M Venture Round | Business Growth Fund, Confidus Venture Capital, Round2 Capital Partners |